Practical recommendations for immune-enhancing diets

Journal of Nutrition

Volumn 134, Issue 10 SUPPL., 2004, Pages

  Bistrian, Bruce Ryan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

(n 3) fats; Arginine; Clinical outcome; Immune enhancing diets

Indexed keywords

ARGININE; DOCOSAHEXAENOIC ACID; GLUTAMINE; ICOSANOID; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LIPID; NITRATE; NITRIC OXIDE; NITRITE; NUCLEOTIDE; OMEGA 3 FATTY ACID; PROSTACYCLIN; PROSTAGLANDIN; THROMBOXANE; UREA;

AMINO ACID SYNTHESIS; CATABOLISM; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; CYTOKINE PRODUCTION; DIET; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; INFECTION; INJURY; MACROPHAGE; META ANALYSIS; NUTRIENT; PROSTAGLANDIN SYNTHESIS; SEPSIS; SURGICAL PATIENT; SYSTEMATIC REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 4744376445     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.10.2868s     Document Type: Conference Paper

References (49)

1. Heys, S., Walker, L., Smith, I. & Eremin, O. (1999) Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann. Surg. 229: 467-477.
2. Beale, R., Bryg, D. & Bihari, D. (1999) Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit. Care Med. 27: 2799-2805.
3. Heyland, D., Novak, F., Drover, J., Jain, M., Su, X. & Suchner, U. (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. J. Am. Med. Assoc. 286: 944-953.
4. McGilvery, R. W. (1970) Biochemistry. A Functional Approach, p. 361. W. B. Saunders, Philadelphia, PA, London, UK, & Toronto, ON.
5. Argaman, Z., Young, V., Noviski, N., Castillo-Rosas, L., Xiao-Ming, L., Zurakowski, D., Cooper, M., Davison, C., Tharakan, J. et al. (2003) Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit. Care Med. 31: 591-597.
6. Mills, C., Kincaid, K., Alt, J., Heilman, M. & Hill, A. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164: 6166-6173.
7. Hibbs, J., Vavrin, Z. & Taintor, R. (1987) L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138: 550-565.
8. Bansal, V. & Ochoa, J. (2003) Arginine availability, arginase, and the immune response. Curr. Opin. Clin. Nutr. Metab. Care 6: 223-228.
9. Hibbs, J. (2002) Infection and nitric oxide. J. Infect. Dis. 185: S9-S17.
10. Fink, M. (1999) Modulating the L-arginine-nitric oxide pathway in septic shock: Choosing the proper point of attack. Crit. Care Med. 27: 2019-2022.
11. Ochoa, J., Bernard, A., O'Brien, W., Griffen, M., Maley, M., Rockrich, A., Tsuei, B., Boulanger, B., Kearney, P. & Morris, S. (2001) Arginase I expression and activity in human mononuclear cells after injury. Ann. Surg. 233: 393-399.
12. Barbul, A., Lazarou, S., Efron, D., Wassserkrug, H. & Efron, G. (1990) Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery 108: 331-337.
13. Daly, J., Reynolds, J., Thom, A., Kinsley, L., Dietrick-Gallagher, M., Shou, J. & Ruggleri, B. (1988) Immune and metabolic effects of arginine in the surgical patient. Ann. Surg. 208: 512-523.
14. Tsuei, B., Bernard, A., Shane, M., Shirley, L., Maley, M., Boulanger, B., Kearney, P. & Ochoa, J. (2001) Surgery induces human mononuclear cell arginase I expression. J. Trauma 51: 497-502.
15. Ochoa, J., Udekwu, A., Billlar, T., Curran, R., Cerra, F., Simmons, R. & Peitzman, A. (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214: 621-626.
16. Freund, H., Atamian, S., Holroyde, J. & Fischer, J. (1979) Plasma amino acids as predictors of the severity and outcome of sepsis. Ann. Surg. 190: 571-576.
17. Lorente, J., Delgado, M., Tejedor, C., Mon, E., Hervas, M., Pascual, T., Fernandez-Segoviano, P., Rieppi, G., Soler, A. et al. (1999) Modulation of systemic hemodynamics by exogenous L-arginine in normal and bacteremic sheep. Crit. Care Med. 27: 2474-2479.
18. Caparros, T., Lopez, J. & Grau, T. (2001) Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome. Jour. Par. Enter. Nutr. 25: 299-309.
19. Simopoulos, A. (1991) Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54: 438-463.
20. Needleman, P., Raz, A., Minkes, M., Ferrendelli, J. & Sprecher, H. (1979) Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc. Natl. Acad. Sci. U.S.A. 76: 944-948.
21. Endres, S., Ghorbani, R., Kelley, V., Georgilis, K., Lonnemann, G., van der Meer, J., Cannon, J., Rogers, T., Klempner, M. S. et al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin 1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320: 265-271.
22. Grimble, R., Howell, W., O'Reilly, G., Turner, S., Markovic, O., Hirrell, S., East, J. & Calder, P. (2002) The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am. J. Clin. Nutr. 76: 454-459.
23. Daly, J., Redmond, H., Cheng, A. & Kinsella, J. (1991) Arginine, RNA and omega-3 fatty acid supplemented enteral feeding enhances immune function in the surgical patient. In: European Society for Parenteral and Enteral Nutrition Clinical Congress, p. 33 (abs.).
24. Switzer, K., McMurray, D., Morris, J. & Chapkin, R. (2003) (n-3) Polyunsaturated fatty acids promote activation-induced cell death in murine T lymphocytes. J. Nutr. 133: 496-503.
25. Bertollni, G., Iapichino, G., Radrizzani, D., Facchini, R., Simini, B., Bruzzone, P., Zanforlin, G. & Tognoni, G. (2003) Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Int. Care Med. 29: 834-840.
26. Hall, J., Dobb, G., Hall, J., Desousa, R., Brennan, L. & McCauley, R. (2003) A prospective randomized trial of enteral glutamine in critical illness. Int. Care Med. 29: 1710-1716.
27. Garrel, D., Patenaude, J., Nedelec, B., Samson, L., Dorais, J., Champoux, J., Delia, M. & Bernier, J. (2003) Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit. Care Med. 31: 2444-2449.
28. Kenler, A., Swails, W., Driscoll, D., DeMichele, S., Daley, B., Babineau, T., Peterson, M. & Bistrian, B. (1996) Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann. Surg. 223: 316-333.
29. Gadek, J., DeMichele, S., Karlstad, M., Pacht, E., Donahoe, M., Albertso, T., Van Hoozen, C., Wennberg, A., Nelson, J. & Noursalehi, M. (1999) Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit. Care Med. 27: 1409-1420.
30. Atkinson S., Sieffert, E. & Bihari, D. (1998) A prospective, randomized, double blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group. Crit. Care Med. 26: 1164-1172.
31. Galban, C., Montejo, J., Mesejo, A., Marco, P., Celaya, S., Sanchez-Segura, J., Farre, M. & Bryg, D. (2000) An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit. Care Med. 28: 643-648.
32. Gianotti, L., Braga, M., Nespoli, L., Radaelli, G., Beneduce, A. & Di Carlo, V. (2002) A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastr. 122: 1763-1770.
33. Braga, M., Gianotti, L., Nespoli, L., Radaelli, G. & Di Carlo, V. (2002) Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch. Surg. 137: 174-180.
34. Braga, M., Gianotti, L., Vignali, A. & Carlo, V. D. (2002) Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 132: 805-814.
35. Snyderman, C. H., Kachman, K., Molseed, L., Wagner, R., D'Amico, F., Bumpous, J. & Rueger, R. (1999) Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 109: 915-921.
36. Tepaske, R., Velthuis, H., Oudemans-van Straaten, H. M., Heisterkamp, S. H., van Deventer, S. J., Ince, C., Eysman, L. & Kesecioglu, J. (2001) Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 358: 696-701.
37. Bower, R., Cerra, F., Bershadsky, B., Licari, J., Hoyt, D., Jensen, G., Van Buren, C., Rothkopf, M., Daly, J. & Adelsberg, B. (1995) Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit. Care Med. 23: 436-449.
38. Montejo, J. (1999) Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit. Care Med. 27: 1447-1453.
39. Schunn, C. & Daly, J. (1995) Small bowel necrosis associated with postoperative jejunal tube feeding. J. Amer. Coll. Surg. 180: 410-416.
40. Scaife, C., Saffie, J. & Morris, S. (1999) Intestinal obstruction secondary to enteral feedings in bum trauma patients. J. Trauma 47: 859-863.
41. Kudsk, K. A., Minard, G., Croce, M. A., Brown, R. O., Lowrey, T. S., Pritchard, F. E., Dickerson, R. N. & Fabian, T. C. (1996) A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann. Surg. 224: 531-543.
42. Moore, A., Moore, E. E., Kudsk, K. A., Brown, R. O., Bower, R. H., Koruda, M. J., Baker, C. C. & Barbul, A. (1994) Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J. Trauma 37: 607-615.
43. Weimann, A., Bastian, L., Bischoff, W. E., Grotz, M., Hansel, M., Lotz, J., Trautwein, C., Tusch, G., Schlitt, H. J. & Regel, G. (1998) Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition 14: 165-172.
44. Brown, R. O., Hunt, H., Mowatt-Larssen, C. A., Wojtysiak, S. L., Henningfield, M. F. & Kudsk, K. A. (1994) Comparison of specialized and standard enteral formulas in trauma patients. Pharmacotherapy 14: 314-320.
45. Mendez, C., Jurkovich, G. J., Garcia, I., Davis, D., Parker, A. & Maier, R. V. (1997) Effects of an immune-enhancing diet in critically injured patients. J. Trauma 42: 933-941.
46. Houdijk, A. P., Rijnsburger, E. R., Jansen, J., Wesdorp, R. I., Weiss, J. K., McCamish, M. A., Teerlink, T., Meuwissen, S. G., Haarman, H. J. et al. (1998) Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 352: 772-776.
47. Jones, C., Palmer, T. E. & Griffiths, R. D. (1999) Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition 15: 108-115.
48. Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P. & Bouillon, R. (2001) Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345: 1359-1367.
49. Pazirandeh, S., Maykel, J. A. & Bistrian, B. R. (2003) Hidden nutrition studies. Crit. Care Med. 31: 662.